Armando Anido
2017
In 2017, Armando Anido earned a total compensation of $2.4M as Chairman of the Board and Chief Executive Officer at Zynerba Pharmaceuticals, a 172% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $287,971 |
|---|---|
| Option Awards | $1,564,522 |
| Salary | $551,668 |
| Other | $43,864 |
| Total | $2,448,025 |
Anido received $1.6M in option awards, accounting for 64% of the total pay in 2017.
Anido also received $288K in non-equity incentive plan, $551.7K in salary and $43.9K in other compensation.
Rankings
In 2017, Armando Anido's compensation ranked 4,531st out of 14,666 executives tracked by ExecPay. In other words, Anido earned more than 69.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,531 out of 14,666 | 69th |
Division Manufacturing | 1,596 out of 5,772 | 72nd |
Major group Chemicals And Allied Products | 459 out of 2,075 | 78th |
Industry group Drugs | 353 out of 1,731 | 80th |
Industry Pharmaceutical Preparations | 280 out of 1,333 | 79th |
Source: SEC filing on April 23, 2018.
Anido's colleagues
We found two more compensation records of executives who worked with Armando Anido at Zynerba Pharmaceuticals in 2017.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019